“…Additional chemotherapeutic alternatives for GBM include anti-angiogenic medicines such as tyrosine kinase inhibitors, anti-VEGF monoclonal antibodies, anti-FGF antibodies, and monoclonal antibodies targeting EGFR (Erlotinib and Gefitinib). 37,38…”
Section: Different Treatments For Glioblastomamentioning
pathways involved in its development and progression. Despite numerous attempts to develop effective treatments, the survival rate remains low. Therefore understanding the molecular mechanisms of these pathways can aid in...
“…Additional chemotherapeutic alternatives for GBM include anti-angiogenic medicines such as tyrosine kinase inhibitors, anti-VEGF monoclonal antibodies, anti-FGF antibodies, and monoclonal antibodies targeting EGFR (Erlotinib and Gefitinib). 37,38…”
Section: Different Treatments For Glioblastomamentioning
pathways involved in its development and progression. Despite numerous attempts to develop effective treatments, the survival rate remains low. Therefore understanding the molecular mechanisms of these pathways can aid in...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.